Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man.

William B. Horton, David A. Joyner, William P. Daley, Karen T. Pitman, Majid A. Khan

Research output: Contribution to journalArticlepeer-review

Abstract

Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.

Original languageEnglish (US)
Pages (from-to)E7-10
JournalEar, nose, & throat journal
Volume90
Issue number6
DOIs
StatePublished - Jun 2011

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man.'. Together they form a unique fingerprint.

Cite this